|
Title: A patient is administered telithromycin (Ketek) to treat a community-acquired pneumonia. A change in ... Post by: Franceswwx on Mar 6, 2019 A patient is administered telithromycin (Ketek) to treat a community-acquired pneumonia. A change in what blood level may necessitate a reduction in the dosage?
A)Creatinine B)AST and ALT C)CPK D)Differential Title: A patient is administered telithromycin (Ketek) to treat a community-acquired pneumonia. A change in ... Post by: lmalma on Mar 6, 2019 A
Feedback: For patients who have renal impairment, together with hepatic impairment, it is essential to reduce the dosage to 400 mg once daily. Alterations in CPK, white cell differential, and liver enzymes may not require a change in the dosage. |